» Articles » PMID: 2110596

Activation of a Beta-galactosidase Recombinant Provirus: Application to Titration of Human Immunodeficiency Virus (HIV) and HIV-infected Cells

Overview
Journal J Virol
Date 1990 Jun 1
PMID 2110596
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

A quantitative bioassay for human immunodeficiency viruses has been developed on the basis of the ability of the tat gene to transactivate the expression of an integrated beta-galactosidase gene in a HeLa-CD4+ cell line. Infection by a single virion of HIV-1 or HIV-2 corresponds to a unique blue syncytium or a cell cluster detected after fixation and addition of 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (a beta-galactosidase substrate). The number of infected lymphoid cells in a culture (stimulated human peripheral blood lymphocytes and cell lines) can also be quantified by cell-to-cell transmission of HIV into the HeLa-CD4(+)-beta-galactosidase monolayer. Infections by simian immunodeficiency viruses are similarly detected. This assay has been used to determine the dose response of drugs, the half-life of HIV at 37 degrees C, and the appearance of infectious particles after virus infection.

Citing Articles

The TAF10-containing TFIID and SAGA transcriptional complexes are dispensable for early somitogenesis in the mouse embryo.

Bardot P, Vincent S, Fournier M, Hubaud A, Joint M, Tora L Development. 2017; 144(20):3808-3818.

PMID: 28893950 PMC: 5650055. DOI: 10.1242/dev.146902.


Small molecule inhibitors of the LEDGF site of human immunodeficiency virus integrase identified by fragment screening and structure based design.

Peat T, Rhodes D, Vandegraaff N, Le G, Smith J, Clark L PLoS One. 2012; 7(7):e40147.

PMID: 22808106 PMC: 3393750. DOI: 10.1371/journal.pone.0040147.


Influenza virus assays based on virus-inducible reporter cell lines.

Li Y, Larrimer A, Curtiss T, Kim J, Jones A, Baird-Tomlinson H Influenza Other Respir Viruses. 2011; 3(5):241-51.

PMID: 21462401 PMC: 4940803. DOI: 10.1111/j.1750-2659.2009.00095.x.


EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitors.

Kremb S, Helfer M, Heller W, Hoffmann D, Wolff H, Kleinschmidt A Antimicrob Agents Chemother. 2010; 54(12):5257-68.

PMID: 20876377 PMC: 2981278. DOI: 10.1128/AAC.00515-10.


Rev-dependent indicator T cell line.

Wu Y, Beddall M, Marsh J Curr HIV Res. 2007; 5(4):394-402.

PMID: 17627502 PMC: 2366165. DOI: 10.2174/157016207781024018.


References
1.
Emerman M, Guyader M, Montagnier L, Baltimore D, Muesing M . The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. EMBO J. 1987; 6(12):3755-60. PMC: 553846. DOI: 10.1002/j.1460-2075.1987.tb02710.x. View

2.
Felber B, Pavlakis G . A quantitative bioassay for HIV-1 based on trans-activation. Science. 1988; 239(4836):184-7. DOI: 10.1126/science.3422113. View

3.
Fauci A . The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science. 1988; 239(4840):617-22. DOI: 10.1126/science.3277274. View

4.
Nara P, Fischinger P . Quantitative infectivity assay for HIV-1 and-2. Nature. 1988; 332(6163):469-70. DOI: 10.1038/332469a0. View

5.
Nolan G, Fiering S, Nicolas J, Herzenberg L . Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc Natl Acad Sci U S A. 1988; 85(8):2603-7. PMC: 280046. DOI: 10.1073/pnas.85.8.2603. View